586 Index
mobility
acupuncture 552
cryotherapy 139
geriatric patients 468 , 471–472, 472
mobilization. see chiropractic/spinal manipulation;
joint mobilization and manipulation
modalities. see physical modalities
Model Standards for Veterinary Physical
Rehabilitation Practice (AARV) 100
moment of resistance (MoR), spinal 439 , 439–440
monounsaturated fatty acids 88 , 88
morphine 483
motivation, canine
aquatic therapy 221–222
therapeutic exercise 187
working dogs 523–525, 525, 529–530
motor nerve conduction studies 511–512
MRI scans. see magnetic resonance
mu agonists, pain management 483–484
mu antagonists, pain management 484
muscle atrophy, geriatric patients 458 , 458–459,
465 , 473
muscle memory, gait training/retraining 32
muscle open‐chain actions, orthopedic
evaluation 341
muscles. see also pelvic muscle strains
cytokines 55–56
healing 114
hypertrophy/sarcopenia 54–55
myosin–actin interaction 53 , 54
organization/motor activity 51–53, 52
thoracic injuries 345–348, 346
muscle strength. see also strength training
geriatric patients 465. see also muscle atrophy
low‐level laser therapy/ photobiomodulation 158
neuromuscular electrical stimulation 150–151
therapeutic swimming 213–214
therapeutic ultrasound 146
thermal agents 139, 142
transcutaneous electrical nerve stimulation 152
musculoskeletal system 43–44. see also bone;
cartilage; muscles
biomechanics 556 , 556–557
cellular components 44
collagen 44–45, 45
elastin 45–46
geriatric patients 458 , 458–459, 473
glycosaminoglycans 46–47, 47
mesenchymal stem cells 44, 49, 50
ontogeny/development 47–49, 48
proteoglycans 46 , 46–47
stress–strain curve 50, 50 , 51
structure–function relationships 50–51
synovium 64 , 64–66, 65
tendons/ligaments/entheses 66–68, 67 , 68
mushing events 5 , 249
myofascial release (MFR), soft tissue treatment 124
myosin–actin interactions, muscles 53 , 54
National Research Council (NRC), energy and
nutrient requirements for dogs 75, 78
neoplasms
aging/senescence 457, 463
pain management 495
spinal disorders 442
nerve conduction studies 511–512
nerve growth factor (NGF) 491
nerve root entrapment, spinal disorders 441
neurokinin‐1 (NK‐1) antagonists 491
neurological conditions, geriatric patients
464–467
neurological impairments, therapeutic exercise
194–199
neurological rehabilitation, therapeutic exercise
201–204
neurology, functional 555–556
neuromuscular conditions, geriatric patients
464–467
neuromuscular electrical stimulation (NMES) 148
flexibility 150
healing 149–150
muscle strength 150–151
for pain 149
treatment parameters 148–149
neuromuscular facilitation 99, 101, 107, 108
therapeutic swimming 214
underwater treadmill work 224 , 224
neuromusculoskeletal evaluation, rehabilitation
105–108
neutering age, history‐taking 20
New Zealand green lipped mussel 90
nitronaproxen 482
NMDA receptor antagonism, pain management 486
noncompetition athletes 10
nonsteroidal anti‐inflammatory drugs
(NSAIDS) 313, 481–482
acute pain 492
carpal injuries 321
chronic pain 494, 495
osteoarthritis 90
shoulder disorders 299, 304
nonsurgical paraparesis 101 , 101
nosework 4
NSAIDs. see nonsteroidal anti‐inflammatory drugs
nuclear scintigraphy 510–511
nutrition 72–73, 90
body condition score 78
carbohydrate loading 82–83
case study 83, 90
conditioning programs 231–232
dietary fiber 83, 87
energy generation 73 , 73–75, 74 , 75
energy utilization at rest and during exercise
75–78
essential and non‐essential amino acids 78
fat/carbohydrate utilization 79–82, 80 , 82
fat classification 88
feeding strategies 86–87
geriatric patients 460, 467
medium and long‐chain triglycerides 82
minerals and electrolytes 83–84, 84
omega‐3 and omega‐6 fatty acids 89